Natpara (parathyroid hormone) for Injection, 25 mcg/dose, 2 pack cartridges, Rx only, For subcutaneous use only, Manufactured for: Shire-NPS Pharmaceuticals, Inc., Lexington, MA NDC 68875-0202-02
Published October 2, 2019 · Recall initiated: September 12, 2019
Summary
FDA records drug Class I recall D-0035-2020, published October 2, 2019 and initiated September 12, 2019. Recalling firm: Shire Human Genetic Therapies, Inc.; Status: Terminated; Reported quantity: 1,556; Lot: 08569357, exp 4/30/2020; 07983652, 08544833, exp 6/30/2021. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Shire Human Genetic Therapies, Inc.
- Distributor
- Product was distributed throughout the United States.
- Lot
- 08569357, exp 4/30/2020; 07983652, 08544833, exp 6/30/2021
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANatpara (parathyroid hormone) for Injection, 100 mcg, 2 pack medication cartridges, Rx only, For subcutaneousOctober 2, 2019
- FDAZarontin (ethosuximide capsules, USP) 250 mg, 100-count bottle, Rx Onl,y Made in Netherlands Distributed byOctober 2, 2019
- FDAminolira (minocycline hydrochloride) extended-release tablets 135 mg* Physician Sample Not for Sale 5 Tablets,October 2, 2019
- FDAAD-TECH Drill Sleeve Guides, used with Ad-Tech Placement Kits: (a) REF DSG-90-2.3N (b) REF DSG-6.3-090-2.4NSeptember 25, 2019
- FDASubcutaneous Implantable Cardioverter Defibrillator (S-ICD) System, labeled as EMBLEMTM S-ICD Pulse GeneratorSeptember 25, 2019
- FDAVPRIV® (velaglucerase alfa for injection) , Lyophilized Powder, 400 Units/vial, Rx Only. Shire Human GeneticApril 30, 2014
Questions about this recall
Was Natpara (parathyroid hormone) for Injection, 25 mcg/dose, 2 pack cartridges, Rx only, For subcutaneous use only, Manufactured for: Shire-NPS Pharmaceuticals, Inc., Lexington, MA NDC 68875-0202-02 recalled?
Yes. FDA published recall D-0035-2020 on October 2, 2019. Reported hazard: Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing
What should I do if I have this product?
Voluntary: Firm initiated · Letter